A removal could lead to outflows of up to $8.8 billion if other index providers follow suit because the stock is part of many passive investment products.Markets, Strategy, Bitcoin Treasury Reserve Asset, MSCI, NewsRead More

You might also be interested in reading Johnson & Johnson raises 2025 sales guidance by $2B and targets $50B oncology sales by 2030 amid robust Q2 performance.